Last Updated: November 16, 2026

Details for Patent: 8,722,619

« Back to Dashboard


Which drugs does patent 8,722,619 protect, and when does it expire?

Patent 8,722,619 protects REZZAYO and is included in one NDA.

This patent has thirty-three patent family members in twenty-one countries.

Summary for Patent: 8,722,619
Title:Antifungal agents and uses thereof
Abstract:The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
Inventor(s):Kenneth Duke James, JR., Christopher Patrick Laudeman
Assignee: NAPP PHARMACEUTICAL GROUP Ltd
Application Number:US13/886,972
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Dosage form;

Drugs Protected by US Patent 8,722,619

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mundipharma REZZAYO rezafungin acetate POWDER;INTRAVENOUS 217417-001 Mar 22, 2023 RX Yes Yes 8,722,619 ⤷  Start Trial Y Y TREATMENT OF CANDIDEMIA AND INVASIVE CANDIDIASIS WITH REZAFUNGIN BY INTRAVENOUS ADMINISTRATION ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,722,619

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2680873 ⤷  Start Trial 301280 Netherlands ⤷  Start Trial
European Patent Office 2680873 ⤷  Start Trial CA 2024 00025 Denmark ⤷  Start Trial
European Patent Office 2680873 ⤷  Start Trial PA2024520 Lithuania ⤷  Start Trial
European Patent Office 2680873 ⤷  Start Trial LUC00351 Luxembourg ⤷  Start Trial
European Patent Office 2680873 ⤷  Start Trial 2024C/527 Belgium ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.